0:000:00
2017-05-02 Special English<br>This is Special English. I'm Ryan Price in Beijing. Here is the news.<br>An international medical journal's retraction of 107 research papers from China, many of them by clinical doctors, has reignited concerns over academic credibility in the country. <br>Tumor Biology, a journal published by Springer Nature, announced a couple weeks ago that it had retracted the papers after an investigation showed the peer review process had been compromised. <br>Peter Butler, editorial director for cell biology and biochemistry at Springer Nature, said the articles were submitted with reviewer suggestions, which had real researcher names but fabricated email addresses.<br>Butler told Shanghai-based news website The Paper that the editors thought the articles were being sent to genuine reviewers in the discipline. Following investigation and communication with the real reviewers, they confirmed they did not conduct the peer review. <br>Peer review is an evaluation of wo...